Itchy eyes can be uncomfortable, even crazy-making, and many of us experience them at one time or another. If you’re ...

Beyond the classic symptoms of watery eyes and sniffles, there are more unusual ones, which can be mistaken for other things. Experts reveal what to look out for ...

A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch ...

This viral infection can be passed to other people through droplets from a cough or sneeze of someone with German measles.

This approval marks the eighth disease indication for Dupixent as a new alternative for patients—many of whom are elderly and ...

The surge in cases is closely tied to seasonal weather patterns—intermittent rains, fluctuating temperatures, and high ...

Dupixent approved by FDA for bullous pemphigoid, offering a new option for adults with the rare autoimmune skin disease ...

Paris: Sanofi has received approval from the US Food and Drug Administration (FDA) for Dupixent (dupilumab) for the treatment ...

Cycle Pharmaceuticals announced that the FDA has approved HARLIKU (nitisinone) Tablets for the reduction of urine ...

Aldeyra has resubmitted its new drug application for reproxalap, an investigational dry eye treatment, which contained new ...

TARRYTOWN, N.Y. and PARIS, June 07, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: REGN) and Sanofi today presented results from the DISCOVER Phase 4, single-arm, open-label trial assessing Dupixent ® (dupilumab) ...

Cycle Pharmaceuticals announced that the FDA has approved HARLIKU (nitisinone) Tablets for the reduction of urine homogentisic acid (HGA) in adult patients with AKU.1 Launching in July 2025, HARLIKU ...